Ning Zhang

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Ying Sun, Wen-Fei Li, Nian-Yong Chen et al. · The Lancet Oncology · 2016 · 950 citations

Medicine, Oncology, Radiation Oncology +14

Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long‐term results of phase 3 randomized controlled trial

Wen‐Fei Li, Nian‐Yong Chen, Ning Zhang et al. · International Journal of Cancer · 2019 · 249 citations

Medicine, Oncology, Radiation Oncology +15

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Yu‐Pei Chen, Xu Liu, Qin Zhou et al. · The Lancet · 2021 · 234 citations

Medicine, Oncology, Pharmacology +12

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma

Ling‐Long Tang, Rui Guo, Ning Zhang et al. · JAMA · 2022 · 175 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

You‐Ping Liu, Yihui Wen, Jun Tang et al. · The Lancet Oncology · 2021 · 157 citations

Medicine, Oncology, Surgery +12